Enanta Pharmaceuticals To Present Data For Zelicapavir, Oral, Once-Daily, N-Protein Inhibitor In Development For Treatment Of Respiratory Syncytial Virus At IDWeek 2026

Benzinga

2026.10.13 11:03 (GMT+0)

Открыть на Benzinga